ELAVL2, ELAV like RNA binding protein 2, 1993

N. diseases: 199; N. variants: 9
Disease: Tumor Progression ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0178874
Disease: Tumor Progression
Tumor Progression 		0.040 Biomarker phenotype BEFREE Therefore, these hub genes might be the key genes contributed to tumor progression or metastasis in PCa and provide candidate therapeutic targets for PCa. 31637138 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression 		0.040 Biomarker phenotype BEFREE Finally, <i>NARS2</i> and <i>TPT1</i> in OV, <i>SMYD2, EGLN1, TNFRSF10D, FUT11, SYTL3, MMP8</i> and <i>EREG</i> in CESC, and <i>SLC5A1, TXN, KDM4B, TXNDC11, HSDL2, COX16, MGAT4A, DAGLA, ELOVL7, THRB</i> and <i>PCOLCE2</i> in UCEC were identified as hub genes in cancer progression. 31788113 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression 		0.040 Biomarker phenotype BEFREE Hub gene identification combined with survival analyses determined RHCG as a candidate biomarker for cancer progression and prognosis prediction. 31170090 2019
CUI: C0178874
Disease: Tumor Progression
Tumor Progression 		0.040 Biomarker phenotype BEFREE Previous studies indicate that 14-3-3ζ is a central cellular hub protein that regulates multiple signaling pathways involved in cancer progression. 29963182 2018